A panel of genes were chosen that included fetal genes known to be re-expressed in ventricular hypertrophy (ANF and Myh7) and genes known to be dysregulated during hypertrophy (skeletal actin and phospholamban). This evidence concerns the gene PLN and cardiac hypertrophy.